预防性静脉注射去甲肾上腺素对腰麻下剖宫产产妇及新生儿的影响
作者: |
1张进,
1王绍林
1 芜湖市第二人民医院麻醉科,安徽 芜湖 241000 |
通讯: |
王绍林
Email: wuhuwsl@163.com |
DOI: | 10.3978/j.issn.2095-6959.2020.06.008 |
摘要
目的:观察预防性静脉注射去甲肾上腺素对腰麻下剖宫产产妇血压、心率(heart rate,HR)和新生儿的影响。方法:择期在腰麻下行剖宫产术单胎足月产妇100例,按照随机数字表法将产妇分为去甲肾上腺素组(NE组)与生理盐水组(C组)。腰麻实施后立即摆仰卧位,手术床向左倾斜15°,快速同步输注羟乙基淀粉,同时即刻静脉注射试剂4 mL(NE组为去甲肾上腺素8 μg,C组为生理盐水)。观察并记录蛛网膜下腔给药后转平卧位时到胎儿取出之间每分钟的收缩压(systolic blood pressure,SBP)和HR,同时记录产妇低血压、高血压、心动过缓和恶心呕吐等不良反应的发生例数、追加使用去甲肾上腺素例数和次数、胎儿取出后1 min和5 min Apgar评分以及脐动、静脉血气分析。结果:鞘内给药后NE组SBP在第3分钟达峰点,在第9分钟时出现最低点,而C组在第6、第10、第14分钟时出现低值。与C组比较,NE组SBP更趋稳定(P<0.05)。NE组HR在给药后呈下降趋势,在第4分钟时为最低值,第9分钟时达最高值。C组在给药后HR第6分钟时上升至最高值。两组产妇高血压和窦性心动过缓发生例数比较无明显差异(P>0.05),但NE组产妇出现低血压和恶心呕吐例数明显少于C组(P<0.05),追加NE例数与次数NE组均明显少于C组(P<0.05)。两组新生儿脐动静脉血气分析以及1 min和5 min Apgar评分比较无明显差异。结论:预防性静脉注射去甲肾上腺素8 μg可有效减少产妇腰麻后低血压和恶心呕吐的发生,同时对新生儿无不利影响。
关键词:
去甲肾上腺素;剖宫产术;腰麻;低血压
Effect of prophylactic intravenous injection of norepinephrine on parturient and neonate during cesarean section under lumbar anesthesia
CorrespondingAuthor: WANG Shaolin Email: wuhuwsl@163.com
DOI: 10.3978/j.issn.2095-6959.2020.06.008
Abstract
Objective: To observe the effect of prophylactic intravenous injection of norepinephrine on maternal blood pressure, heart rate and neonate during cesarean section under lumbar anesthesia. Methods: A total of 100 single full-term parturients scheduled for cesarean section under lumbar anesthesia were divided into two groups with 50 cases each according to random number table method. Group NE was injected norepinephrine and group C was for the control group. After lumbar anesthesia successful, patients were placed in supine position immediately, and the operating bed was tilted to the left at 15°. Hydroxyethyl starch was infused rapidly and synchronously, and group NE received boluses of norepinephrine 8 μg (2 μg/mL) and the same 4 mL capacity of normal saline for group C. SBP and HR were observed and recorded every minute from supine position after subarachnoid administration to fetal removal. The incidence of adverse reactions such as maternal hypotension, hypertension, bradycardia and nausea and vomiting were also recorded. The case and frequency used additional norepinephrine, Apgar scores at 1 minute and 5 minutes after fetal removal, and umbilical cord blood gas values were also recorded. Results: SBP in group NE reached the peak at the 3rd minute after intrathecal administration, and reached the lowest point at the 9th minute, but the low values were occurred at the 6th, 10th and 14th minute in group C. Compared with group C, SBP in group NE was more stable (P<0.05). HR in group NE showed a downtrend after administration, and HR reached the lowest point at 4th minute and the highest at the 9th minute. HR in group C increased to the highest level at the 6th min after administration. There was no significant difference in the incidence of hypertension and sinus bradycardia between the 2 groups (P>0.05), but the incidence of hypotension and nausea and vomiting in group NE were significantly lower than those in group C (P<0.05), and the number and frequency of additional NE in group NE were significantly lower than those in group C (P<0.05). There was no significant difference in umbilical artery and vein blood gas analysis and Apgar scores at 1 min and 5 min between the 2 groups. Conclusion: Prophylactic intravenous injection of norepinephrine 8 μg could effectively reduce the occurrence of hypotension and nausea and vomiting after lumbar anesthesia in parturients, and has no adverse effects on newborns.
Keywords:
norepinephrine; cesarean section; lumbar anesthesia; hypotension